Close Menu

NEW YORK (GenomeWeb News) – Sigma-Aldrich said after the close of the market Wednesday that it has established a new $600 million revolving credit facility.

The new facility matures on May 10, 2017, and replaces a $450 million facility that was scheduled to mature on Dec. 11, 2012. The firm said that the facility will provide it with back up liquidity and will be used for general corporate purposes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.